Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Migraine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    August 2020
  1. LIPTON RB, Cohen JM, Gandhi SK, Yang R, et al
    Effect of Fremanezumab on Quality of Life and Productivity in Patients With Chronic Migraine.
    Neurology. 2020 Aug 3. pii: WNL.0000000000010000.
    PubMed     Abstract available


    July 2020
  2. THALER AI, Kim BD, Fara MG
    Teaching NeuroImages: MR Perfusion and Diffusion Findings in Hemiplegic Migraine.
    Neurology. 2020 Jul 9. pii: WNL.0000000000010249.
    PubMed    


  3. GOADSBY PJ, Reuter U, Hallstrom Y, Broessner G, et al
    One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study.
    Neurology. 2020 Jul 7. pii: WNL.0000000000010019.
    PubMed     Abstract available


    June 2020
  4. LIPTON RB, Buse DC, Friedman BW, Feder L, et al
    Characterizing opioid use in a US population with migraine: Results from the CaMEO study.
    Neurology. 2020 Jun 11. pii: WNL.0000000000009324.
    PubMed     Abstract available


    May 2020

  5. Vascular safety of erenumab for migraine prevention.
    Neurology. 2020 May 7. pii: WNL.0000000000009310.
    PubMed    


  6. KUMAR A, Bhatia R, Sharma G, Dhanlika D, et al
    Effect of yoga as add-on therapy in migraine (CONTAIN): A randomized clinical trial.
    Neurology. 2020 May 6. pii: WNL.0000000000009473.
    PubMed     Abstract available


    April 2020
  7. SLAVOVA N, Denier N, El-Koussy M, Wiest R, et al
    The index vein pointing to the origin of the migraine aura symptom: A case series.
    Neurology. 2020 Apr 23. pii: WNL.0000000000009493.
    PubMed     Abstract available



  8. Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
    Neurology. 2020 Apr 23. pii: WNL.0000000000009280.
    PubMed    


    March 2020
  9. LIPTON RB, Goadsby PJ, Smith J, Schaeffler BA, et al
    Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.
    Neurology. 2020 Mar 24. pii: WNL.0000000000009169.
    PubMed     Abstract available


    February 2020
  10. COSTELLO FE, Bisdorff AR, Robbins MS
    Visual snow: Are we beginning to see the light?
    Neurology. 2020;94:241-242.
    PubMed    


  11. PULEDDA F, Schankin C, Goadsby PJ
    Visual snow syndrome: A clinical and phenotypical description of 1,100 cases.
    Neurology. 2020;94:e564-e574.
    PubMed     Abstract available


  12. LEIRA R, Dominguez C
    Author response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:235-236.
    PubMed    


  13. WELCH KMA
    Reader response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:235.
    PubMed    


  14. GUPTA V
    Reader response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:234.
    PubMed    


  15. SHUBHAKARAN K
    Reader response: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:233-234.
    PubMed    


  16. LEWIS A, Galetta S
    Editors' note: Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2020;94:233.
    PubMed    


    January 2020
  17. ROCCA MA, Harrer JU, Filippi M
    Are machine learning approaches the future to study migraine patients?
    Neurology. 2020 Jan 21. pii: WNL.0000000000008956.
    PubMed    


  18. TU Y, Zeng F, Lan L, Li Z, et al
    An fMRI-based neural marker for migraine without aura.
    Neurology. 2020 Jan 21. pii: WNL.0000000000008962.
    PubMed     Abstract available


  19. MULLIN K, Kudrow D, Croop R, Lovegren M, et al
    Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
    Neurology. 2020 Jan 13. pii: WNL.0000000000008944.
    PubMed     Abstract available


    December 2019
  20. KUDROW D, Pascual J, Winner PK, Dodick DW, et al
    Vascular safety of erenumab for migraine prevention.
    Neurology. 2019 Dec 18. pii: WNL.0000000000008743.
    PubMed     Abstract available


  21. BERTISCH SM, Li W, Buettner C, Mostofsky E, et al
    Nightly sleep duration, fragmentation, and quality and daily risk of migraine.
    Neurology. 2019 Dec 16. pii: WNL.0000000000008740.
    PubMed     Abstract available



  22. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Dec 10. pii: WNL.0000000000008728.
    PubMed    



  23. Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Dec 10. pii: WNL.0000000000008750.
    PubMed    


    November 2019
  24. TAN RYY, Traylor M, Megy K, Duarte D, et al
    How common are single gene mutations as a cause for lacunar stroke? A targeted gene panel study.
    Neurology. 2019 Nov 12. pii: WNL.0000000000008544.
    PubMed     Abstract available


  25. LIPTON RB, Fanning KM, Buse DC, Martin VT, et al
    Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2019 Nov 5. pii: WNL.0000000000008589.
    PubMed     Abstract available


    October 2019
  26. LAHUE SC, Gelfand AA, Bove RM
    Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?
    Neurology. 2019;93:668-672.
    PubMed     Abstract available


  27. SEN S
    Author response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2019;93:646-647.
    PubMed    


  28. HSIEH CY
    Reader response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2019;93:646.
    PubMed    


  29. GUPTA V
    Reader response: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2019;93:645-646.
    PubMed    


  30. LEWIS A, Galetta S
    Editors' note: Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2019;93:645.
    PubMed    


    September 2019
  31. BEH SC, Friedman DI
    Acute vestibular migraine treatment with noninvasive vagus nerve stimulation.
    Neurology. 2019 Sep 25. pii: WNL.0000000000008388.
    PubMed     Abstract available



  32. Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2019;93:608.
    PubMed    


    August 2019
  33. ZIEGELER C, May A
    Facial presentations of migraine, TACs, and other paroxysmal facial pain syndromes.
    Neurology. 2019 Aug 21. pii: WNL.0000000000008124.
    PubMed     Abstract available


  34. OSKOUI M, Pringsheim T, Holler-Managan Y, Potrebic S, et al
    Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Aug 14. pii: WNL.0000000000008095.
    PubMed     Abstract available


  35. OSKOUI M, Pringsheim T, Billinghurst L, Potrebic S, et al
    Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Neurology. 2019 Aug 14. pii: WNL.0000000000008105.
    PubMed     Abstract available


  36. TEE TY, Khoo CS, Raymond AA, Syazarina SO, et al
    Teaching NeuroImages: Neuroimaging in hemiplegic migraine.
    Neurology. 2019;93:e626-e627.
    PubMed    


    July 2019
  37. VAN DONGEN RM, Waaijer LC, Onderwater GLJ, Ferrari MD, et al
    Treatment effects and comorbid diseases in 58 patients with visual snow.
    Neurology. 2019;93:e398-e403.
    PubMed     Abstract available


  38. ROBBINS MS
    Comment: Time for neurologists to see visual snow.
    Neurology. 2019;93:153.
    PubMed    


  39. ARKINK EB, Palm-Meinders IH, Koppen H, Milles J, et al
    Microstructural white matter changes preceding white matter hyperintensities in migraine.
    Neurology. 2019 Jul 11. pii: WNL.0000000000007940.
    PubMed     Abstract available


  40. FORD JH, Ayer DW, Zhang Q, Carter JN, et al
    Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.
    Neurology. 2019 Jul 3. pii: WNL.0000000000007856.
    PubMed     Abstract available


    June 2019
  41. YOUNG AS, Lechner C, Bradshaw AP, MacDougall HG, et al
    Capturing acute vertigo: A vestibular event monitor.
    Neurology. 2019;92:e2743-e2753.
    PubMed     Abstract available


    May 2019
  42. TU Y, Fu Z, Zeng F, Maleki N, et al
    Abnormal thalamo-cortical network dynamics in migraine.
    Neurology. 2019 May 10. pii: WNL.0000000000007607.
    PubMed     Abstract available


  43. COPPOLA G, Di Renzo A, Petolicchio B, Tinelli E, et al
    Aberrant interactions of cortical networks in chronic migraine: A resting-state fMRI study.
    Neurology. 2019 May 3. pii: WNL.0000000000007577.
    PubMed     Abstract available


    April 2019
  44. LIPTON RB, Tepper SJ, Reuter U, Silberstein S, et al
    Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
    Neurology. 2019 Apr 17. pii: WNL.0000000000007452.
    PubMed     Abstract available


  45. TEPPER SJ, Diener HC, Ashina M, Brandes JL, et al
    Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
    Neurology. 2019 Apr 17. pii: WNL.0000000000007497.
    PubMed     Abstract available


  46. ONDERWATER GLJ, Ligthart L, Bot M, Demirkan A, et al
    Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007313.
    PubMed     Abstract available


    March 2019
  47. ALBRECHT DS, Mainero C, Ichijo E, Ward N, et al
    Imaging of neuroinflammation in migraine with aura: A [(11)C]PBR28 PET/MRI study.
    Neurology. 2019 Mar 27. pii: WNL.0000000000007371.
    PubMed     Abstract available


  48. FILIPPI M, Messina R, Goadsby PJ, Rocca MA, et al
    Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:587-588.
    PubMed    


  49. GUPTA VK
    Reader response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:587.
    PubMed    


  50. SIEGLER JE 3RD, Galetta S
    Editors' note: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2019;92:586.
    PubMed    


  51. LAPUCCI C, Saitta L, Bommarito G, Sormani MP, et al
    How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
    Neurology. 2019 Mar 8. pii: WNL.0000000000007266.
    PubMed     Abstract available


    February 2019
  52. DOMINGUEZ C, Lopez A, Ramos-Cabrer P, Vieites-Prado A, et al
    Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine.
    Neurology. 2019 Feb 1. pii: WNL.0000000000007047.
    PubMed     Abstract available


    January 2019
  53. LEE MJ, Park BY, Cho S, Park H, et al
    Cerebrovascular reactivity as a determinant of deep white matter hyperintensities in migraine.
    Neurology. 2019 Jan 4. pii: WNL.0000000000006822.
    PubMed     Abstract available


    December 2018
  54. GELAYE B, Sacco S, Brown W, Nitchie H, et al
    Author response: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1074.
    PubMed    


  55. GUPTA VK
    Reader response: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1073.
    PubMed    


  56. LEWIS A, Galetta S
    Editors' note: Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2018;91:1073.
    PubMed    


    November 2018
  57. REISMAN AM, Robbins BT, Chou DE, Yugrakh MS, et al
    Ticagrelor for Refractory Migraine/Patent Foramen Ovale (TRACTOR): An open-label pilot study.
    Neurology. 2018;91:1010-1017.
    PubMed     Abstract available


  58. SOMMER RJ, Nazif T, Privitera L, Robbins BT, et al
    Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale.
    Neurology. 2018;91:1002-1009.
    PubMed     Abstract available


  59. DETKE HC, Goadsby PJ, Wang S, Friedman DI, et al
    Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study.
    Neurology. 2018 Nov 16. pii: WNL.0000000000006640.
    PubMed     Abstract available


  60. KUCA B, Silberstein SD, Wietecha L, Berg PH, et al
    Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
    Neurology. 2018 Nov 16. pii: WNL.0000000000006641.
    PubMed     Abstract available


  61. FRIDMAN S, Sposato LA
    Migraine with visual aura, incident AF, and stroke risk: Is migraine with aura an embolic TIA?
    Neurology. 2018 Nov 14. pii: WNL.0000000000006637.
    PubMed    


  62. SEN S, Androulakis XM, Duda V, Alonso A, et al
    Migraine with visual aura a risk factor for incident atrial fibrillation: A cohort study.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006650.
    PubMed     Abstract available


    August 2018
  63. VEREB D, Szabo N, Tuka B, Tajti J, et al
    Correlation of neurochemical and imaging markers in migraine: PACAP38 and DTI measures.
    Neurology. 2018 Aug 22. pii: WNL.0000000000006201.
    PubMed     Abstract available


  64. VANDERPLUYM J, Dodick DW, Lipton RB, Ma Y, et al
    Fremanezumab for preventive treatment of migraine: Functional status on headache-free days.
    Neurology. 2018 Aug 17. pii: 01.wnl.0000544321.19316.
    PubMed     Abstract available


    June 2018
  65. VAN OOSTERHOUT WPJ, Schoonman GG, van Zwet EW, Dekkers OM, et al
    Female sex hormones in men with migraine.
    Neurology. 2018 Jun 27. pii: WNL.0000000000005855.
    PubMed     Abstract available


  66. MESSINA R, Rocca MA, Colombo B, Pagani E, et al
    Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005819.
    PubMed     Abstract available


  67. TASSORELLI C, Grazzi L, de Tommaso M, Pierangeli G, et al
    Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.
    Neurology. 2018 Jun 15. pii: WNL.0000000000005857.
    PubMed     Abstract available


  68. LIPTON RB, Goadsby PJ
    Comment: Noninvasive neurostimulation for migraine should be part of the general neurologist's therapeutic armamentarium.
    Neurology. 2018 Jun 15. pii: WNL.0000000000005870.
    PubMed    


    April 2018
  69. SCHULTE LH, Allers A, May A
    Visual stimulation leads to activation of the nociceptive trigeminal nucleus in chronic migraine.
    Neurology. 2018 Apr 27. pii: WNL.0000000000005622.
    PubMed     Abstract available


    March 2018
  70. EL YOUSSEF N, Maalouf N, Mourad A, Saade J, et al
    Teaching NeuroImages: Retinal migraine in action.
    Neurology. 2018;90:e992.
    PubMed    


    January 2018
  71. PELZER N, Haan J, Stam AH, Vijfhuizen LS, et al
    Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation.
    Neurology. 2018 Jan 17. pii: WNL.0000000000004966.
    PubMed     Abstract available


    November 2017
  72. KOWALEC K, McKay KA, Patten SB, Fisk JD, et al
    Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004716.
    PubMed     Abstract available


    October 2017
  73. FRIEDMAN BW, Irizarry E, Solorzano C, Latev A, et al
    Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine.
    Neurology. 2017 Oct 18. pii: 10.1212/WNL.0000000000004642.
    PubMed     Abstract available


  74. PALM-MEINDERS IH, Arkink EB, Koppen H, Amlal S, et al
    Volumetric brain changes in migraineurs from the general population.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004640.
    PubMed     Abstract available


    August 2017
  75. FERRONI P, Barbanti P, Aurilia C, Egeo G, et al
    Procoagulant imbalance in premenopausal women with chronic migraine.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004435.
    PubMed    


  76. ASHINA M, Dodick D, Goadsby PJ, Reuter U, et al
    Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004391.
    PubMed     Abstract available


  77. BEAR JJ, Gelfand AA, Goadsby PJ, Bass N, et al
    Occipital headaches and neuroimaging in children.
    Neurology. 2017;89:469-474.
    PubMed     Abstract available


    July 2017
  78. MULLER KI, Alstadhaug KB, Bekkelund SI
    A randomized trial of telemedicine efficacy and safety for nonacute headaches.
    Neurology. 2017;89:153-162.
    PubMed     Abstract available


  79. SCHER AI, Buse DC, Fanning KM, Kelly AM, et al
    Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004177.
    PubMed     Abstract available


    June 2017
  80. ANDROULAKIS XM, Krebs K, Peterlin BL, Zhang T, et al
    Modulation of intrinsic resting-state fMRI networks in women with chronic migraine.
    Neurology. 2017 Jun 14. pii: 10.1212/WNL.0000000000004089.
    PubMed     Abstract available


  81. DE JONG HJI, Kingwell E, Shirani A, Cohen Tervaert JW, et al
    Evaluating the safety of beta-interferons in MS: A series of nested case-control studies.
    Neurology. 2017;88:2310-2320.
    PubMed     Abstract available


    April 2017
  82. SCHULTE LH, Allers A, May A
    Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003963.
    PubMed     Abstract available


  83. GELAYE B, Sacco S, Brown WJ, Nitchie HL, et al
    Body composition status and the risk of migraine: A meta-analysis.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003919.
    PubMed     Abstract available


    March 2017
  84. DASILVA AF, Nascimento TD, Jassar H, Heffernan J, et al
    Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003861.
    PubMed     Abstract available


  85. MONTEITH TS
    Migraine relief: Nonpainful stimulation for acute attacks.
    Neurology. 2017;88:e128-e131.
    PubMed    


  86. YARNITSKY D, Volokh L, Ironi A, Weller B, et al
    Nonpainful remote electrical stimulation alleviates episodic migraine pain.
    Neurology. 2017 Mar 1. pii: 10.1212/WNL.0000000000003760.
    PubMed     Abstract available


    December 2016
  87. ANDROULAKIS XM, Kodumuri N, Giamberardino LD, Rosamond WD, et al
    Ischemic stroke subtypes and migraine with visual aura in the ARIC study.
    Neurology. 2016;87:2527-2532.
    PubMed     Abstract available


  88. SPOSATO LA, Peterlin BL
    Cardioembolism as the unsuspected missing link between migraine and ischemic stroke.
    Neurology. 2016;87:2504-2505.
    PubMed    


    November 2016
  89. SETHI M, Kowalczyk MA, Dalic LJ, Archer JS, et al
    Abnormal neurovascular coupling during status epilepticus migrainosus in Sturge-Weber syndrome.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003492.
    PubMed    


  90. LOUTER MA, Pelzer N, de Boer I, Kuijvenhoven BE, et al
    Prevalence of lifetime depression in a large hemiplegic migraine cohort.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003376.
    PubMed     Abstract available


    October 2016
  91. DESOUZA DD, O'Hare M, Woldeamanuel YW, Cowan RP, et al
    Journal Club: Change in brain network connectivity during PACAP38-induced migraine attacks.
    Neurology. 2016;87:e199-e202.
    PubMed    


  92. WOLDEAMANUEL YW, O'Hare M, DeSouza DD, Cowan RP, et al
    Journal Club: Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
    Neurology. 2016;87:e196-e198.
    PubMed     Abstract available


  93. COPPOLA G, Di Renzo A, Tinelli E, Di Lorenzo C, et al
    Thalamo-cortical network activity during spontaneous migraine attacks.
    Neurology. 2016 Oct 14. pii: 10.1212/WNL.0000000000003327.
    PubMed     Abstract available


  94. VERSLEGERS WR, Leone M, Proietti Cecchini A
    Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache.
    Neurology. 2016;87:1522-1523.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: